HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yoshiki Sakai Selected Research
Yoshiki Sakai Research Topics
Disease
17
Fibrosis (Cirrhosis)
01/2021 - 07/2009
8
Ischemia
09/2020 - 07/2009
5
Infarction (Infarctions)
12/2021 - 03/2012
5
Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
03/2014 - 12/2009
4
Cardiomyopathies (Cardiomyopathy)
12/2021 - 12/2009
4
Myocardial Ischemia (Ischemic Heart Diseases)
06/2019 - 07/2009
3
Myocardial Infarction
12/2021 - 01/2013
3
Wounds and Injuries (Trauma)
08/2021 - 06/2012
3
Ureteral Obstruction
10/2016 - 06/2012
3
Heart Failure
07/2015 - 08/2013
3
Hypertrophy
01/2015 - 10/2012
3
Pulmonary Hypertension
06/2012 - 12/2005
2
Proteinuria
08/2021 - 10/2012
2
Hypertension (High Blood Pressure)
08/2021 - 10/2012
2
Pulmonary Arterial Hypertension
01/2021 - 01/2013
2
Reperfusion Injury
06/2019 - 01/2012
2
Chronic Renal Insufficiency
02/2016 - 01/2015
1
Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2021
1
Rodent Diseases
08/2021
1
Hypoxia (Hypoxemia)
01/2021
1
Breast Neoplasms (Breast Cancer)
01/2021
1
Neoplasms (Cancer)
01/2021
1
Chronic Limb-Threatening Ischemia
09/2020
1
Arteriosclerosis Obliterans
09/2020
1
Neuroinflammatory Diseases
01/2019
1
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2019
1
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2019
1
Disease Progression
01/2019
1
Kidney Diseases (Kidney Disease)
10/2016
1
Acute Kidney Injury (Acute Renal Failure)
12/2015
1
Critical Illness (Critically Ill)
12/2015
1
Inflammation (Inflammations)
07/2015
1
Hyperglycemia
01/2015
1
Diabetic Nephropathies (Diabetic Nephropathy)
01/2015
1
Obesity
01/2015
1
Type 2 Diabetes Mellitus (MODY)
01/2015
1
Albuminuria
01/2015
1
Chronic Pancreatitis
05/2014
1
Myocarditis (Carditis)
01/2013
1
Liver Cirrhosis (Hepatic Cirrhosis)
01/2013
Drug/Important Bio-Agent (IBA)
26
Epoprostenol (Prostacyclin)
FDA Link
Generic
12/2021 - 12/2005
18
ONO 1301
IBA
12/2020 - 12/2005
8
Thromboxanes
IBA
01/2013 - 12/2005
7
Serine Proteinase Inhibitors (Serine Protease Inhibitors)
IBA
08/2021 - 10/2012
7
Collagen
IBA
08/2013 - 07/2009
6
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
12/2013 - 12/2009
5
camostat
IBA
08/2021 - 07/2013
4
Cytokines
IBA
12/2021 - 08/2013
4
Therapeutic Uses
IBA
07/2015 - 06/2012
3
Pharmaceutical Preparations
IBA
01/2021 - 08/2012
3
Proteins (Proteins, Gene)
FDA Link
01/2021 - 10/2012
2
ameroid
IBA
12/2021 - 01/2018
2
Serine Proteases (Serine Protease)
IBA
08/2021 - 10/2016
2
Salts
IBA
10/2016 - 10/2012
2
Adenine
FDA Link
Generic
02/2016 - 01/2015
2
Prostaglandins
IBA
12/2015 - 01/2006
2
Messenger RNA (mRNA)
IBA
01/2015 - 01/2013
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
12/2013 - 12/2009
2
Connective Tissue Growth Factor
IBA
07/2013 - 01/2013
2
Hydroxyproline (4 Hydroxyproline)
IBA
07/2013 - 01/2006
2
Antibodies
IBA
08/2012 - 06/2012
2
Polyglactin 910
IBA
03/2012 - 01/2012
2
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
12/2009 - 07/2009
2
Monocrotaline
IBA
01/2008 - 12/2005
1
Ligases (Synthetase)
IBA
01/2021
1
Nanoparticle Drug Delivery System
IBA
01/2021
1
Solutions
IBA
06/2019
1
Vasodilator Agents (Vasodilators)
IBA
01/2019
1
Glutamic Acid (Glutamate)
FDA Link
01/2019
1
Fibrinolysin
FDA Link
10/2016
1
Aldosterone
IBA
10/2016
1
Telmisartan (Micardis)
FDA Link
02/2016
1
Indicators and Reagents (Reagents)
IBA
07/2015
1
Antioxidants
IBA
01/2015
1
Collagen Type IV (Type IV Collagen)
IBA
01/2015
1
NADPH Oxidases (NAD(P)H oxidase)
IBA
01/2015
1
dibutyldichlorotin
IBA
05/2014
1
Brain Natriuretic Peptide (Natrecor)
FDA Link
03/2014
1
salicylhydroxamic acid (SHAM)
IBA
03/2014
1
Biological Products
IBA
03/2014
1
Cytoskeletal Proteins
IBA
12/2013
1
Sarcoglycans (beta Sarcoglycan)
IBA
12/2013
1
atelocollagen
IBA
12/2013
1
Matrix Metalloproteinase 2 (Gelatinase A)
IBA
07/2013
1
Transforming Growth Factors (Transforming Growth Factor)
IBA
07/2013
1
Plasminogen Activators (Plasminogen Activator)
IBA
07/2013
1
Myosins (Myosin)
IBA
01/2013
1
Neutralizing Antibodies
IBA
01/2013
1
Synthetic Prostaglandins (Prostaglandin Analogues)
IBA
01/2013
1
Collagen Type I (Type I Collagen)
IBA
01/2013
1
Collagen Type III (Type III Collagen)
IBA
01/2013
1
Creatinine
IBA
10/2012
1
nephrin
IBA
10/2012
Therapy/Procedure
4
Therapeutics
01/2019 - 12/2013
3
Subcutaneous Injections
01/2015 - 01/2012
2
Microspheres (Microsphere)
03/2012 - 01/2012
1
Nanospheres
01/2021
1
Cell- and Tissue-Based Therapy (Cell Therapy)
09/2020
1
Oral Administration
01/2013
1
Nephrectomy
10/2012